Mr. Clark, I'd like a written answer. I can also respond to the written answer that you sent today.
At our last meeting, I asked for your views on several proposals. One of them was the idea of a more gradual implementation of the PMPRB's new guidelines. The first step would be to implement the new basket of comparator countries. The pharmacoeconomic factors should then be applied after a more extensive consultation. In addition, a multi-stakeholder evaluation and monitoring committee should be created to make the process more objective.
You responded that several of the measures that I referred to would be part of your plan for the future. A number of these suggestions don't pose any issues.
I'd now like you to be a little more specific about which of these measures might apply and, if so, whether they would apply as of the January 1 deadline.